Mito Health Passes One Million Lab Tests, Expands Into Seven Preventive Testing Categories
核心洞察
Mito Health (搜索) has run more than one million lab tests and expanded from longevity biomarker panels into seven categories of preventive health testing.
The direct-to-consumer catalog now spans over 1,000 lab tests, at-home kits, imaging, whole genome sequencing, specialty kits and multi-cancer early detection.
At-home blood draws are available in 35 states and test kits ship nationwide to all 50 states, with diagnostics priced at cost under a $9 monthly membership.
Mito Health (搜索), the San Francisco-based direct-to-consumer diagnostics company that built its business on longevity biomarker panels, announced on Sept. 2, 2026 that it has run more than one million lab tests and has expanded into seven categories of preventive health testing. The company said customers can now order diagnostics without insurance, a referral or a surprise bill.
For its first two years, Mito Health (搜索) served people ordering panels of more than 100 biomarkers. Its customers now order tests for fertility planning, strength and body composition, baseline markers for chronic diseases, nutrient and heavy-metal screening, inherited disease risk, and tuberculosis (搜索) testing required for school enrollment. According to the company, many of these customers may be between insurance plans or prefer to order tests directly rather than wait for approval.
A Catalog Spanning Labs to Liquid Biopsy
The expanded catalog includes more than 1,000 individual lab tests and panels, ranging from single-marker orders to a 180-plus biomarker panel. At-home test kits ship across all 50 states, while at-home blood draws are available in 35 states. Customers can also walk into partner draw sites nationwide.
Imaging and scans now include DEXA body composition and whole-body MRI, with coronary artery calcium scoring and VO2 max testing scheduled to follow. Whole genome sequencing is offered at both 3x and 30x coverage — a distinction that roughly maps to how thoroughly the genome is read, with the deeper option generally used when more precision is needed. Specialty kits cover gut microbiome analysis and H. pylori (搜索) breath testing, and the company has added liquid biopsy testing aimed at multi-cancer early detection. Supplements and prescriptions are planned and priced the same way.
At-Cost Pricing Under a Flat Membership
Mito Health (搜索) prices diagnostics at cost and is supported by a $9-per-month membership rather than markups, upsells or commissions. HSA and FSA funds are accepted.
"We wanted transparent preventive health prices, at cost, with one health membership," said Kenneth Lou, co-founder and chief executive of Mito Health (搜索). "We earn the same whether someone buys a lot, a little or nothing at all. That is what lets us tell a customer the most useful thing is often to test less, not more."
That position is unusual for a diagnostics company, given that most of the industry's revenue logic runs the other way: more tests ordered, more panels upsold. Mito Health (搜索)'s flat-fee structure removes that incentive on paper, though it remains to be seen whether test volume actually settles into "less, not more" as the catalog grows, or whether a bigger menu simply gives customers more reasons to order.
Expansion Follows Longevity Logic
The company's clinical operations lead framed the breadth of the catalog as a practical matter for patients navigating multiple testing needs.
"People rarely need just one kind of test," said Rhonda Collins, FNP-C, who supports clinical operations at Mito Health (搜索). "Someone looking at fertility, or at family history, often needs bloodwork and imaging and sometimes genetics. Having those in one place means fewer places to get lost."
While the expansion could be read as a drift away from Mito Health (搜索)'s original longevity focus, the more accurate interpretation may be the opposite: fertility planning, chronic-disease baselines, inherited-risk screening and cancer detection are upstream inputs to healthspan tracking rather than separate from it. A 100-plus biomarker panel describes where a body stands today, but genetic risk, imaging and early cancer detection are the pieces that allow someone to act on that picture years before a problem would otherwise surface.
Founded in 2023 and headquartered in San Francisco, Mito Health (搜索) describes itself as a direct-to-consumer diagnostics marketplace offering transparent, at-cost preventive health testing. The full catalog is available at mitohealth.com.